SCHEMBL5262888

SCHEMBL5262888

NC(=O)c1ccccc1Oc1ncccc1-c1ccncn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.48
KDR P35968 4/20 0.47
TEK Q02763 4/20 0.47
CTNNB1 P35222 1/20 0.43
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.41
NR1I2 O75469 1/20 0.41
LMNA P02545 1/20 0.41
CHRM2 P08172 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADRA2A P08913 1/20 0.41
MAPT P10636 1/20 0.41
OPRK1 P41145 1/20 0.41
HTR2B P41595 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KMT2A Q03164 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
CDC7 O00311 1/20 0.41
AURKA O14965 1/20 0.40
AURKB Q96GD4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16654579 0.80 BCAT2 (0.53) RAB9ACYP3A4MAPTCDC7
Hydrochloric Acid SCHEMBL30692651 0.77 BCAT2 (0.50) RAB9ACYP3A4MAPTCDC7
SCHEMBL4879222 0.76 CTNNB1 (0.42) CTNNB1RAB9AMEN1NR1I2LMNA
SCHEMBL5264038 0.76 PDE10A (0.51) PDE10AKDRTEKMEN1KMT2A
SCHEMBL5262512 0.75 KDR (0.58) PDE10AKDRTEKAURKAAURKB
SCHEMBL6631705 0.75 RAB9A (0.56) CTNNB1RAB9AMEN1NR1I2LMNA
SCHEMBL30143171 0.74 PDE10A (0.59) PDE10AKDRTEK
SCHEMBL29134476 0.74 KEAP1 (0.45) CDC7AURKAAURKB
SCHEMBL5260572 0.74 TEK (0.52) KDRTEKAURKAAURKBTPX2
SCHEMBL7098623 0.73 IKBKB (0.43) CDC7AURKBIRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751136-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2007-02-14 EP claimed
WO-2005113494-A2 NITROGENATED HETEROCYCLIC DERIVATIVES AS PROTEIN KINASE MODULATORS AND USE FOR THE TREATMENT OF ANGIOGENESIS AND CANCER AMGEN INC. (US) 2005-12-01 WO claimed